The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
"Please know we have conducted a thorough review of the safety data."
The high protection was found even amid high Alpha and Delta variant circulation.
Covaxin, made by Bharat Biotech, is an inactivated vaccine given in two doses 4 weeks apart.
COVID-19 didn't appear to spread efficiently within and among teams last fall.
Spanish, Italian, and UK physicians reported high levels of depression and anxiety during the first two waves of the COVID-19 pandemic, finds a study yesterday in PLOS One.
The ACIP recommendation now goes to CDC head Walensky for final approval.
A hybrid of natural and vaccine immunity may protect better against breakthrough infections.
Also, new CDC data show why immune-compromised people need an added COVID vaccine dose.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
"As we await CDC's decision, we are not waiting on operations or logistics."
